Skip to main content
. 1998 Jan 1;506(Pt 1):175–194. doi: 10.1111/j.1469-7793.1998.175bx.x

Table 1.

Effectiveness of various dopaminergic agonists in eliciting conductance changes in island of Calleja granule cells

Agonist Latency (min) Vrev,min (mV) Vrev,max (mV) Initial conductance (pS) Maximal conductance (nS) Increase (%) n
Dopamine (300 nm) 7·9 ± 2 * -32·7 ± 4·5 -6·3 ± 0·9 241 ± 47 6·48 ± 3·5 2589 3
Apomorphine (10-300 nm) 6·1 ± 0·9 -36·3 ± 4·3 -5·8 ± 4·0 533 ± 101 5·66 ± 1·8 1271 8
Quinpirole (100 nm)§ 6·6 ± 1·1 -32·0 ± 4·1 -6·2 ± 2·3 592 ± 141 11·81 ± 3·37 3202 5
7-OH DPAT (100-300 nm)§ 7·7 ± 0·73 -42 ± 13 2·7 ± 4·8 280 ± 27 5·5 ± 1·6 1693 3
PD 128907 (300 nm)§ 6·0 ± 0·8 -26·0 ± 4·3 -4·6 ± 1·4 305 ± 43 8·25 ± 1·93 3083 5

The latency was the time between switching to agonist containing ACSF and the onset of the ‘cataclysmic’ component - the large inward current and conductance increase observed at -80 mV.

*

The value for dopamine was derived from current-clamp observations (n = 7); the remainder from voltage-clamp experiments. Reversal potentials at the start of responding (the minimal component; Vrev,min) and at the peak of inward current (Vrev,max) were determined from intersections of extrapolated I-V curves as indicated in Fig. 5. Neuronal input conductance prior to agonist application (initial conductance) and at the peak inward current (maximal conductance) were determined by the slopes of I-V relations between -70 and -100 mV also as indicated in Fig. 5.

§

Experimental series undertaken in ACSF that contained 1 mm Ba2+ Paired t tests were employed to test for differences in Vrev,min and Vrev,max and yielded exact probabilities of P = 0·013

for apomorphine, P = 0·016

for quinpirole and P = 0·021

for PD 128907.